DRUG · Mapped RxNorm record
Interferon alfa-n3
Normalized identity: interferon alfa-n3 View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
NCT00002012
Study summary
ClinicalTrials.govDouble-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
HIV Infectionsunresolved
Interventions
Interferon alfa-n3DRUG · verified · RxNorm: interferon alfa-n3
Sponsors & collaborators
Interferon Scienceslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002012 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.